Asymptomatic HIV testing in Palombara Sabina

Find health labs to test for Asymptomatic HIV in Palombara Sabina and compare all offers by prices and services.

Tests that cover Asymptomatic HIV

HIV Test
test epatite B, epatite C, HIV con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€60.00

€57.00 with our promocode

See Details

Rapid HIV Test by Laboratorio Lifebrain

Viale Roma 00012 Guidonia Montecelio (Guidonia Montecelio)

5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Luigi Einaudi, 33 00013 Mentana (Roma)

6.9 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Galletti 8/10 00012 Guidonia Montecelio (RM)

5 km

Unverified

See Details

Rapid HIV Test by Analisi Cliniche Ciocci Srl

Via Palatina, 00019 Tivoli RM, Italia

7.3 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Tiburtina Valeria, 36 00029 Vicovaro (RM)

7.4 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via della Libertà, 111 00024 Castel Madama (RM)

8.2 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Palombarese, 100 ex km 19.00 00012 Guidonia (Roma)

5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Salaria, 164 00015 Monterotondo (RM)

7.7 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via di Casal Bianco, 141, Roma, RM, Italia 00131 Settecamini (Roma) (RM)

18.8 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Bachelet, 32 00065 Fiano Romano (RM)

11.5 km

Unverified

See Details

Asymptomatic HIV - symptoms and how to test

The second stage of HIV/AIDS involves infection without symptoms. At this time, HIV infection shows no visible symptoms. Patients often seek medical treatment due to symptoms; therefore, asymptomatic infections frequently go undetected. According to an estimate, around 10-60 % of individuals with early HIV infection will not experience symptoms. Patients who are asymptomatic but have HIV infection might benefit from therapies to lower their risk of clinical events and disease transmission if tested and found to have the virus.